Daniel Goldenberg

Hadassah Medical Center — Israel

Medicine · Health Sciences

23h-index1.6kcitations70works0.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Liver Disease Diagnosis and Treatment(18), Drug Transport and Resistance Mechanisms(9), MicroRNA in disease regulation(7), Bacterial Genetics and Biotechnology(7), RNA modifications and cancer(7)

Publications70 total

The oncogenic microRNA miR-222 promotes human LINE-1 retrotransposition
RNA Biology·2025· 1 citedOpen Access
FRI-064 MicroRNA-122 functions as a rheostat regulating liver tolerance, inflammation and fibrosis
Journal of Hepatology·2025
WED-534 MiR122 expression regulates liver immune tolerance and microenvironment
Journal of Hepatology·2024
Gut Microbiota to Microglia: Microbiome Influences Neurodevelopment in the CNS
Children·2023· 9 citedOpen Access
Gut Microbiota Modulation of Short Bowel Syndrome and the Gut–Brain Axis
Nutrients·2023· 15 citedOpen Access
Supplementary Data from Molecular Mechanisms of Liver Carcinogenesis in the Mdr2-Knockout Mice
2023Open Access
Supplementary Data from Molecular Mechanisms of Liver Carcinogenesis in the Mdr2-Knockout Mice
2023Open Access
Data from Molecular Mechanisms of Liver Carcinogenesis in the Mdr2-Knockout Mice
2023Open Access
Data from Molecular Mechanisms of Liver Carcinogenesis in the Mdr2-Knockout Mice
2023Open Access
Supplementary Methods from Multiple Adaptive Mechanisms to Chronic Liver Disease Revealed at Early Stages of Liver Carcinogenesis in the Mdr2-Knockout Mice
2023Open Access
Data from Multiple Adaptive Mechanisms to Chronic Liver Disease Revealed at Early Stages of Liver Carcinogenesis in the Mdr2-Knockout Mice
2023Open Access
Supplementary Figures 1-4 from Multiple Adaptive Mechanisms to Chronic Liver Disease Revealed at Early Stages of Liver Carcinogenesis in the Mdr2-Knockout Mice
2023Open Access
Supplementary Methods from Multiple Adaptive Mechanisms to Chronic Liver Disease Revealed at Early Stages of Liver Carcinogenesis in the Mdr2-Knockout Mice
2023Open Access
Data from Multiple Adaptive Mechanisms to Chronic Liver Disease Revealed at Early Stages of Liver Carcinogenesis in the Mdr2-Knockout Mice
2023Open Access
Supplementary Figures 1-4 from Multiple Adaptive Mechanisms to Chronic Liver Disease Revealed at Early Stages of Liver Carcinogenesis in the Mdr2-Knockout Mice
2023Open Access
Supplementary Tables 1-3 from Multiple Adaptive Mechanisms to Chronic Liver Disease Revealed at Early Stages of Liver Carcinogenesis in the Mdr2-Knockout Mice
2023Open Access
Supplementary Tables 1-3 from Multiple Adaptive Mechanisms to Chronic Liver Disease Revealed at Early Stages of Liver Carcinogenesis in the Mdr2-Knockout Mice
2023Open Access
Combined hepatocellular-cholangiocarcinoma derives from liver progenitor cells and depends on senescence and IL-6 trans-signaling
Journal of Hepatology·2022· 62 citedOpen Access
MiR-122, the regulator of the immune privileged liver
Journal of Hepatology·2022
The lncRNA H19-Derived MicroRNA-675 Promotes Liver Necroptosis by Targeting FADD
Cancers·2021· 49 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Eithan Galun(31), Orit Pappo(17), Devorah Olam(14), Lina Mizrahi(13), Hilla Giladi(12), Naama Klopstock(8), Hila Barash(7), Rinat Abramovitch(7), Mark Katzenellenbogen(7), Amnon Peled(7), Eytan Domany(6), Nofar Rosenberg(6), Ezra Ella(5), Jasmine Jacob‐Hirsch(5), Ninette Amariglio(5), Jonathan H. Axelrod(5), Stefan Rose‐John(5), Tamara Potikha(5), A B Oppenheim(4), Gidi Rechavi(4)